UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of A Novel Her-1/Her-2 Dual Tyrosine Kinase Inhibitor for the Treatment of Her-1 Selective Inhibitor-Resistant Non-small Cell Lung Cancer

Journal of medicinal chemistry, 2009-11, Vol.52 (21), p.6880-6888

2009

Volltextzugriff (PDF)

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

Anti-cancer drugs, 2012-03, Vol.23 (3), p.288-297

2012

Volltextzugriff (PDF)

Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors

European journal of medicinal chemistry, 2010-11, Vol.45 (11), p.5420-5427

2010

Volltextzugriff (PDF)

Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models

International journal of cancer, 2012-05, Vol.130 (10), p.2445-2454

2012

Volltextzugriff (PDF)

Selective inhibition of MDR1 (ABCB1) by HM30181 increases oral bioavailability and therapeutic efficacy of paclitaxel

European journal of pharmacology, 2010-02, Vol.627 (1), p.92-98

2010

Volltextzugriff (PDF)

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer

Cancer letters, 2011-03, Vol.302 (2), p.155-165

2011

Volltextzugriff (PDF)

Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice

PloS one, 2014-04, Vol.9 (4), p.e95733

2014

Volltextzugriff (PDF)

Structure-based virtual screening of Src kinase inhibitors

Bioorganic & medicinal chemistry, 2009-04, Vol.17 (8), p.3152-3161

2009

Volltextzugriff (PDF)

Oral paclitaxel chemotherapy for brain tumors : Ideal combination treatment of paclitaxel and P-glycoprotein inhibitor

Oncology reports, 2008, Vol.19 (1), p.17-23

2008

Volltextzugriff (PDF)

Response of brain specific microenvironment to P-glycoprotein inhibitor : An important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors

International journal of oncology, 2008-10, Vol.33 (4), p.705-712

2008

Volltextzugriff (PDF)

Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model

Circulation (New York, N.Y.), 2004-03, Vol.109 (12), p.1558-1563

2004

Volltextzugriff (PDF)

Antihypertensive Effects of Enantiomers of Amlodipine Camsylate, a Novel Salt of Amlodipine

Biomolecules & therapeutics, 2007-03, Vol.15 (1), p.40-45

2007

Volltextzugriff (PDF)

Antitumor activity of ZD6474 in a metastatic orthotopic brain tumor model

Molecular medicine reports, 2008-05, Vol.1 (3), p.343-346

2008

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of Pyrimidine-Based Dual Inhibitors of Human Epidermal Growth Factor Receptor 1 (HER-1) and HER-2 Tyrosine Kinases

Journal of medicinal chemistry, 2012-03, Vol.55 (6), p.2846-2857

2012

Volltextzugriff (PDF)

Aminostyrylbenzofuran directly reduces oligomeric amyloid-[beta] and reverses cognitive deficits in alzheimer transgenic mice

PloS one, 2014-04, Vol.9 (4)

2014

Volltextzugriff (PDF)

Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer’s disease treatment

Bioorganic & medicinal chemistry letters, 2013-06, Vol.23 (11), p.3467-3469

2013

Volltextzugriff (PDF)

cDNA microarray gene expression analysis and toxicological phenotype for anticancer drug

Journal of Veterinary Medical Science, 2004, Vol.66(11), pp.1339-1345

2004

Volltextzugriff (PDF)

Abstract 4660: Antiproliferative effects of antagonists of Inhibitor of Apoptosis Proteins (IAPs) in human cancer cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4660-4660

2012

Volltextzugriff (PDF)

Abstract LB-389: Antitumor activity of HM781–36B, a highly effective pan -HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.LB-389-LB-389

2011

Volltextzugriff (PDF)

Abstract 592: Novel IAP antagonist (822B) induces apoptosis through degradation of IAP proteins which have a BIR3 domain in human pancreatic cancer cells

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.592-592

2011

Volltextzugriff (PDF)

Abstract B260: Antitumor activity of HM781-36B, an irreversible pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer cells

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B260-B260

2009

Volltextzugriff (PDF)

Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid- beta and Reverses Cognitive Deficits in Alzheimer Transgenic Mice: e95733

PloS one, 2014-04, Vol.9 (4)

2014

Volltextzugriff (PDF)

P3‐276: Amyloidogenesis targeting small molecule as a drug candidate

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_17), p.S532-S533

2010

Volltextzugriff (PDF)

Amyloidogenesis targeting small molecule as a drug candidate

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S532-S533

2010

Volltextzugriff (PDF)

KMS88009 and KMS88016 as small molecule inhibitors for in vivo Aβ fibril formation

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P421-P421

2009

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(62)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of A Novel Her-1/Her-2 Dual Tyrosine Kinase Inhibitor for the Treatment of Her-1 Selective Inhibitor-Resistant Non-small Cell Lung Cancer

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors

Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models

Selective inhibition of MDR1 (ABCB1) by HM30181 increases oral bioavailability and therapeutic efficacy of paclitaxel

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer

Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice

Structure-based virtual screening of Src kinase inhibitors

Oral paclitaxel chemotherapy for brain tumors : Ideal combination treatment of paclitaxel and P-glycoprotein inhibitor

Response of brain specific microenvironment to P-glycoprotein inhibitor : An important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors

Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model

Antihypertensive Effects of Enantiomers of Amlodipine Camsylate, a Novel Salt of Amlodipine

Antitumor activity of ZD6474 in a metastatic orthotopic brain tumor model

Synthesis and Biological Evaluation of Pyrimidine-Based Dual Inhibitors of Human Epidermal Growth Factor Receptor 1 (HER-1) and HER-2 Tyrosine Kinases

Aminostyrylbenzofuran directly reduces oligomeric amyloid-[beta] and reverses cognitive deficits in alzheimer transgenic mice

Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer’s disease treatment

cDNA microarray gene expression analysis and toxicological phenotype for anticancer drug

Abstract 4660: Antiproliferative effects of antagonists of Inhibitor of Apoptosis Proteins (IAPs) in human cancer cells

Abstract LB-389: Antitumor activity of HM781–36B, a highly effective pan -HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models

Abstract 592: Novel IAP antagonist (822B) induces apoptosis through degradation of IAP proteins which have a BIR3 domain in human pancreatic cancer cells

Abstract B260: Antitumor activity of HM781-36B, an irreversible pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer cells

Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid- beta and Reverses Cognitive Deficits in Alzheimer Transgenic Mice: e95733

P3‐276: Amyloidogenesis targeting small molecule as a drug candidate

Amyloidogenesis targeting small molecule as a drug candidate

KMS88009 and KMS88016 as small molecule inhibitors for in vivo Aβ fibril formation

Suchergebnisse filtern